Estimating In Vivo Levonorgestrel Release Rate and Exposure Over Eight Years With Levonorgestrel Releasing Intrauterine System 52 mg Use With Population Pharmacokinetic Approach [A03]. (May 2022)
- Record Type:
- Journal Article
- Title:
- Estimating In Vivo Levonorgestrel Release Rate and Exposure Over Eight Years With Levonorgestrel Releasing Intrauterine System 52 mg Use With Population Pharmacokinetic Approach [A03]. (May 2022)
- Main Title:
- Estimating In Vivo Levonorgestrel Release Rate and Exposure Over Eight Years With Levonorgestrel Releasing Intrauterine System 52 mg Use With Population Pharmacokinetic Approach [A03]
- Authors:
- Jensen, Jeffrey T.
Reinecke, Isabel
Lukkari-Lax, Eeva
Hofmann, Birte M. - Abstract:
- Abstract : INTRODUCTION: To characterize performance of the levonorgestrel releasing intrauterine system (LNG-IUS) 52 mg (Mirena) for 8 years of use (currently approved for 7 years) and facilitate comparisons with LNG-IUS 19.5 mg and LNG-IUS 13.5 mg, we estimated in vivo LNG release rates and LNG plasma/serum concentrations using a population pharmacokinetic (popPK) approach with data from the Mirena Extension Trial (MET) and earlier clinical trials. METHODS: Previously, we developed a popPK model based on measured plasma/serum LNG concentrations and residual LNG content from removed 52 mg, 19.5 mg, and 13.5 mg LNG-IUS devices in clinical studies for up to 5 years of use, estimating in vivo LNG release and describing LNG exposure. To estimate release and exposure for years 6–8 of use, we applied the model to data for 6, 7, and finally 8 years from the MET. RESULTS: As expected, LNG release rates for LNG-IUS 52 mg were higher than for 19.5 mg and 13.5 mg devices. After 8 years, LNG-IUS 52 mg release rate (7.04 µg/day) was similar to LNG-IUS 19.5 mg after 5 years (7.6 µg/day) and higher than LNG-IUS 13.5 mg after 3 years (5.5 µg/day). Model-based estimated and measured LNG concentrations showed good agreement, with average plasma LNG concentrations after 8 years LNG-IUS 52 mg (100ng/L [CV%: 39.9%]) similar to after 5 years LNG-IUS 19.5 mg (84.8ng/L [39.9%]) and higher than after 3 years LNG-IUS 13.5 mg (58.1ng/L [40.8%]) use. CONCLUSION: LNG release rates from LNG-IUS 52 mg atAbstract : INTRODUCTION: To characterize performance of the levonorgestrel releasing intrauterine system (LNG-IUS) 52 mg (Mirena) for 8 years of use (currently approved for 7 years) and facilitate comparisons with LNG-IUS 19.5 mg and LNG-IUS 13.5 mg, we estimated in vivo LNG release rates and LNG plasma/serum concentrations using a population pharmacokinetic (popPK) approach with data from the Mirena Extension Trial (MET) and earlier clinical trials. METHODS: Previously, we developed a popPK model based on measured plasma/serum LNG concentrations and residual LNG content from removed 52 mg, 19.5 mg, and 13.5 mg LNG-IUS devices in clinical studies for up to 5 years of use, estimating in vivo LNG release and describing LNG exposure. To estimate release and exposure for years 6–8 of use, we applied the model to data for 6, 7, and finally 8 years from the MET. RESULTS: As expected, LNG release rates for LNG-IUS 52 mg were higher than for 19.5 mg and 13.5 mg devices. After 8 years, LNG-IUS 52 mg release rate (7.04 µg/day) was similar to LNG-IUS 19.5 mg after 5 years (7.6 µg/day) and higher than LNG-IUS 13.5 mg after 3 years (5.5 µg/day). Model-based estimated and measured LNG concentrations showed good agreement, with average plasma LNG concentrations after 8 years LNG-IUS 52 mg (100ng/L [CV%: 39.9%]) similar to after 5 years LNG-IUS 19.5 mg (84.8ng/L [39.9%]) and higher than after 3 years LNG-IUS 13.5 mg (58.1ng/L [40.8%]) use. CONCLUSION: LNG release rates from LNG-IUS 52 mg at 8 years are similar to 19.5 mg at 5 years and higher than 13.5 mg at 3 years. The 8-year popPK model provides in vivo LNG release rate and concentration estimates, facilitating more direct comparisons between the three LNG-IUSs. … (more)
- Is Part Of:
- Obstetrics and gynecology. Volume 139(2022)Supplement 1
- Journal:
- Obstetrics and gynecology
- Issue:
- Volume 139(2022)Supplement 1
- Issue Display:
- Volume 139, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 139
- Issue:
- 1
- Issue Sort Value:
- 2022-0139-0001-0000
- Page Start:
- 1S
- Page End:
- 1S
- Publication Date:
- 2022-05
- Subjects:
- Obstetrics -- Periodicals
Gynecology -- Periodicals
618 - Journal URLs:
- http://journals.lww.com/greenjournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/01.AOG.0000826348.24505.fe ↗
- Languages:
- English
- ISSNs:
- 0029-7844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6208.200000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22480.xml